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Abstract
People with asthma suffer from impaired health-related quality of life (HRQL), but the determinants of HRQL among
asthmatics are not completely understood. The aim of this investigation was to study determinants of low HRQL in asthmatics
and to study whether the determinants of HRQL differ between sexes and age groups. A cohort of three age groups in Sweden
was investigated in 1990 using a questionnaire with focus on respiratory symptoms. To study quality of life, the generic
instrument Gothenburg Quality of Life was used. The participants were also investigated with interviews, spirometry, and
allergy testing. Asthma was diagnosed in 616 subjects. Fifty-eight per cent (n = 359) of the subjects were women; and 24% were
smokers, 22% ex-smokers, and 54% were non-smokers. Women were more likely than men to report poor health-
related quality of life. Respiratory symptoms severity was another independent determinant of a lower quality of life as
well as airway responsiveness to irritants. Current and former smokers also reported lower quality of life. Finally, absenteeism
from school and work was associated with lower quality of life. Factors such as sex, smoking habits, airway responsiveness to
irritants, respiratory symptom severity, allergy, and absenteeism from school and work were associated with low HRQL in
asthmatics.
Key words: Asthma, GQL, generic instrument, quality of life
Introduction
Health-related quality of life (HRQL) assessment is
increasingly used as an outcome measure in asthma
and other chronic respiratory diseases. Asthma is a
common chronic disease worldwide, with an esti-
mated 300 million affected individuals (1), and the
prevalence of asthma in Sweden is about 10% (2).
Asthma exerts a substantial adverse impact on the
lives of many people with this condition (3). Although
people with asthma suffer from impaired quality of life
compared with people without asthma (4), the deter-
minants of quality of life among people with clinically
veriﬁed asthma have not been thoroughly explored
(3). Reduced HRQL has been associated with
female sex, young age, low lung function, low edu-
cational level, region of living, co-morbidity, use of
inhaled bronchodilators and corticosteroids, wheez-
ing, chronic cough, sputum production, and bron-
chial hyper-responsiveness (5,6). Our results from
previous analyses of HRQL in asthmatics show that
subjects with asthma had a higher level of non-respi-
ratory symptoms and that subjects with low HRQL at
baseline were more likely to develop asthma at follow-
up 13 years later (7).
Understanding the determinants of quality of life in
asthma, especially potentially modiﬁable ones, can be
helpful in designing interventions that improve the
quality of life in asthmatics (3). The primary aim of
the present study was to study determinants of low
Correspondence: Professor Anna Rask-Andersen MD PhD, Department of Medical Sciences, Occupational and Environmental Medicine, University Hospital,
SE751 85 Uppsala, Sweden. E-mail: anna.rask-andersen@medsci.uu.se
(Received 30 September 2011; accepted 3 November 2011)
ISSN 0300-9734 print/ISSN 2000-1967 online   2012 Informa Healthcare
DOI: 10.3109/03009734.2011.638730HRQL in clinically veriﬁed asthmatics. A secondary
aim was to study whether the determinants of
HRQL were different in men and women as well as
in younger and older asthmatics.
Material and methods
Study design and sample
This study includes participants from two counties in
Sweden: Jämtland and Gävleborg. In the 1990 cohort
study, subjects were selected from the responders to a
questionnaire focusing on respiratory symptoms sent
to all individuals 16 years of age and to a random
sample of the age groups of 30–39 and 60–69 years
(8). A total of 11,294 subjects (89%) answered
the questionnaire on respiratory symptoms. In a sec-
ond phase, all subjects who reported a history of
asthma, chronic bronchitis, or respiratory symptoms
(n = 1,851) were invited to a clinical investigation
including spirometry, allergy testing, and assessment
of HRQL using the Gothenburg Quality of Life
(GQL) questionnaire. The participation rate was
73%. In addition, a random sample of 600 subjects
without a history of respiratory diseases and respira-
tory symptoms were invited to this phase of the
investigation (8). The present analysis was based on
616 subjects with clinically veriﬁed asthma (Figure 1).
Measurements
Questionnaire on respiratory symptoms. The postal
questionnaire was based on the British Medical
Research Council questionnaire, later modiﬁed
and used in previous studies in northern Sweden
(9,10). The questionnaire consisted of 22 items
including questions on the following: attacks of
dyspnoea, shortness of breath, or breathlessness;
wheezing in the chest; prolonged productive
cough; use of anti-asthmatic medication; and
physician’s diagnosis of asthma, chronic bronchitis,
or emphysema.
Gothenburg Quality of Life instrument. Subjective
HRQL was measured in 1990 using the generic
Gothenburg Quality of Life instrument (11). Part
one of the instrument covers 30 common symptoms
from various parts of the body; the respondents answer
‘yes’ or ‘no’ to questions on whether they had expe-
rienced any of the symptoms during the previous
3 months. The number of symptoms was summarized
into a score. In order to be able to compare with the
well-being scores below, the scale was transformed to a
ﬁve-step score and inverted. Thus a score of ﬁve means
no symptoms at all, and a score of zero means ‘yes’ to
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Figure 1. Study population and subgroups 1990–2003.
58 M. Leander et al.Part two of the instrument focusing on well-
being includes 18 items covering subjective physical,
mental, and social well-being. The respondent
answers each item on a seven-step Likert scale ranging
from 1 = ‘very bad’,t o7= ‘excellent/could not be
better’. A high score therefore indicates a better level
of well-being. An index was calculated for each of the
three well-being scales by summarizing all items
within each scale for each respondent and then divid-
ing with the number of items within each scale (4).
GQL has been validated using a Swedish population
sample and by analysing biomedical variables (11).
Clinical measurements. Lung function was tested with
pneumotachographs (Vitalograph Alpha, London,
UK).Vital capacity (VC)and forced expiratory volume
in 1 second (FEV1) were measured. This study
adhered to the American Thoracic Society (ATS)
(12) recommendations for spirometry testing. A skin
prick test was performed using Phazet devices (Phar-
macia Diagnostics, Uppsala, Sweden), which are stain-
less lancets pre-coated with extracts of ten common
allergens (13). Lancets with allergen were applied on
the skin inside the forearm. A skin test was said to be
positive ifthe mean wheal diameter was 3 mm ormore.
Asthma diagnosis
Asthma was diagnosed if all of the following symp-
toms and ﬁndings were present (8): 1) repeated
attacks of wheezing during the last year; 2) repeated
attacks of dyspnoea with shortness of breath during
the last year; 3) identiﬁed exogenous agents (at least
three including allergens or unspeciﬁc factors) pro-
voking shortness of breath and/or wheezing; 4) com-
plete recovery between attacks; and 5) best FEV1
‡80% of predicted.
If the history suggested asthma with repeated epi-
sodes of dyspnoea and/or wheezing in the last year and
at least one positive answer to questions on wheezing or
on long-standing dry cough, but did not meet the above
criteria, the diagnosis was conﬁrmed by at least one of
the following observations: 1) reversibility of 15% from
initial value in FEV1 after salbutamol inhalation; 2)
variability in PEF (peak expiratory ﬂow) ‡20% (ampli-
t u d e%m e a n )3o f7d a y s ;3 )P C 2 0£4m g / m Lo r
PD20 £2.6 mg (PC20 = provocative concentration of a
substance (methacholine) causing a 20% fall in FEV1;
PD20 = dose of histamine provoking a fall in FEV1 of
20%); and 5) best FEV1 ‡80% of predicted.
Determinants
From the investigation in 1990 with respiratory ques-
tionnaires and interviews by a trained nurse the fol-
lowing questions were chosen in order to estimate
determinants of asthma. The process of choosing
these variables was based on discussions in the
research team and also on earlier research and clinical
experience.
Severity of respiratory symptoms. The severity of current
obstructive symptoms was classiﬁed into four groups:
no symptoms, wheeze during the last year, nightly
symptoms such as wheezing or breathlessness or
asthma attacks during the last year, and breathlessness
during most days of the week.
Allergy tests. The subjects were graded into ﬁve groups
depending of the results of the skin prick tests. Sub-
jects with no reaction to either animal dander, pollen,
mould, or mites were classiﬁed into the ﬁrst group,
while subjects with reactions to all four types of
allergens were classiﬁed into the ﬁfth group.
Airway responsiveness to irritants. Symptoms indicating
bronchial hyper-responsiveness to irritants were clas-
siﬁed into six groups depending on the answers to ﬁve
questions about breathlessness on exhaustion in cold
air during the winter, and wheezing or severe cough
after exposure to dust, cigarette smoke, vehicle
exhaust/air pollution, strong smells, or cold air. Sub-
jects with no such symptoms were graded into group
1 while subjects answering ‘yes’ to all ﬁve questions
were grouped to the sixth group.
Asthma medication. The asthma medication was graded
into four groups depending on how heavy the medica-
tion was. The ﬁrst group included subjects with no
treatment, the second group subjects who were on
bronchodilators, the third group subjects with inhala-
tion steroids, and the fourth group subjects on oral
steroids.
Emergency visits because of breathing problems. The ﬁrst
group included subjects who had never attended emer-
gency medical care because of respiratory symptoms,
the second group subjects with emergency visit to a
physician, and the third group subjects who had been
admitted to hospital because of respiratory symptoms.
Sick-leave caused by respiratory symptoms. Sick-leave
caused by respiratory symptoms was graded into ﬁve
groups depending on the number of days the subject
had been absent from work or school because of
respiratory symptoms in the last 12 months. In the
ﬁrst group the subjects had not been off work or
school at all because of respiratory symptoms, in
the second group the subjects had been off up to
8 days, in the third group 8–30 days, in the fourth
group 30–90 days, and in the ﬁfth group the subjects
had been off work or school more than 90 days
because of respiratory symptoms.
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Associations between the outcome variables (symp-
tom score, physical well-being, mental well-being,
and social well-being) and the explanatory variables
were studied using multivariate linear regression.
Although separate linear regression models ﬁtted to
each of the outcome variables would give similar point
estimates and standard errors, the use of a multivar-
iate model allowed us to perform a single test of each
explanatory variable on all four outcomes simulta-
neously. This minimizes the risk of interpreting an
effect on e.g. one of the outcome variables as signif-
icant when the overall test across all outcomes proved
inconclusive. Prior to ﬁtting the regression model, the
symptom score was reversed and re-scaled to match
the range of the other outcome variables so that a
higher score represented fewer symptoms.
In an initial model ﬁt, all categorical explanatory
variables with more than two categories were entered
as factors, yielding a separate effect estimate for each
level except the reference level. We then performed a
joint test of all categorical variables where our null
hypothesis was that all categorical variables could be
represented as an ordinal variable, i.e. as a linear term
in the regression model. As the test was highly sig-
niﬁcant we proceeded to test which, if any, of the
categorical variables could be modelled linearly
choosing a P value cut-off of 0.2. The ﬁnal model
ﬁt included the same pre-speciﬁed variables as the
initial ﬁt but with four variables modelled as categor-
ical and the rest modelled linearly. We then pro-
ceeded by testing four pre-speciﬁed interactions:
sex and age, each interacting with airway reactivity
and symptoms, and wheeze. All interaction terms with
P values £ 0.2 were kept in the model. Finally resi-
duals from the model were assessed with respect to
normality and homogeneity by visually inspecting
normal quartile plots and plots of the residuals versus
the ﬁtted values as well as versus the explanatory
variables.
Several of the variables contained missing values.
To account for the missing data, multiple imputations
of the missing values have been recommended in the
literature (14). We used multivariate imputation
using chained equations (15) to create 15 imputed
data sets and included in the imputation model all
four outcome variables and all potential explanatory
variables.
Residuals from the model showed no gross devia-
tions from normality when plotted against normal
quartiles, although the residuals for the mental score
outcome showed slightly heavy tails indicating slight
left-skewness. Plots of the residuals versus ﬁtted
values and residuals versus the explanatory variables
revealed no recognizable pattern, indicating that
model assumptions may not have been severely
violated.
Imputation, model ﬁtting and the residual analysis
were done using Stata version 11.
Ethical approval
The study was approved by the Ethics Committee at
the University of Umeå (§222, 1989-12-12) and the
Ethics Committee, Faculty of Medicine, Uppsala
(Dnr. 01–313).
Results
The characteristics of the study sample in asthma
subjects are presented in Table I. More than half of
the members of all age-groups were women. The
youngest age group had signiﬁcantly more positive
allergy tests, and the two youngest age groups also
reported more hyper-responsiveness to irritants and
allergic rhinitis. The oldest age groups had signiﬁ-
cantly more severe symptoms of asthma and lower
FEV1. A higher asthma medication score was signif-
icantly more prevalent in the oldest age group. The
smoking habits and use of oral tobacco differed sig-
niﬁcantly between the age groups, with more smokers
among the 30–39-year-olds compared to the 16-year-
olds. The younger age groups were signiﬁcantly more
absent from work and school. The oldest age group
lived signiﬁcantly more often in an apartment, but the
16-year-olds lived more often in a house and in a city.
The symptom score and mental well-being did not
differ between the age groups, but the oldest age
group had lower physical well-being, and the younger
age groups had lower social well-being.
Five determinants were independently related to
impaired health-related quality of life in asthmatic
subjects: female sex, hyper-responsiveness score,
symptom severity, smoking habits, and absenteeism
from work/school (Table II). Women were more
likely than men to report poor health-related quality
of life (Figure 2). Respiratory symptoms severity was
another independent determinant of a lower quality
of life as well as airway responsiveness to irritants
(Table II). Current and former smokers also
reported lower quality of life. Finally, absenteeism
from school or work was associated with lower qual-
ity of life.
The result of an interaction analysis indicated
(P = 0.19) that a higher symptom score had more
impact in women and to a certain degree also mental
and social well-being, while symptom score seemed to
have quite similar effects on the physical well-
being between the sexes.
60 M. Leander et al.Table I. The characteristics of the study sample (n (%) and mean ± SD).
All (n = 616) 16 y (n = 160) 30–39 y (n = 233) 60–69 y (n = 223) P value
Women 359 (58) 85 (53) 138 (59) 136 (61) 0.29
FEV1 % of predicted 93 ± 15 96 ± 39 4 ± 15 90 ± 17 < 0.05
Skin prick test reactivity
None 293 (48) 53 (33) 72 (31) 168 (75) < 0.001
1 type of allergen
a 132 (21) 30 (19) 57 (25) 45 (20)
2 types of allergens 124 (20) 46 (29) 72 (31) 6 (3)
3 types of allergens 51 (8) 24 (15) 24 (10) 3 (1)
4 types of allergens 15 (2) 7 (4) 7 (3) 1 (0)
Airway responsiveness to irritants
None 55 (9) 10 (6) 21 (9) 24 (11) < 0.01
1 irritant 112 (18) 31 (19) 42 (18) 39 (17)
2 irritants 144 (23) 38 (24) 56 (24) 50 (22)
3 irritants 157 (26) 46 (29) 65 (28) 46 (21)
4 irritants 108 (18) 27 (17) 39 (17) 42 (19)
5 irritants 38 (16) 8 (5) 8 (3) 22 (10)
Respiratory symptom severity
None 57 (9) 15 (9) 22 (9) 20 (9) < 0.01
Wheeze last year 90 (15) 27 (17) 43 (18) 20 (9)
Nocturnal symptoms 402 (65) 108 (68) 148 (64) 146 (65)
Daily symptoms 67 (11) 10 (6) 20 (9) 37 (17)
Allergic rhinitis 231 (43) 75 (50) 107 (53) 49 (27) < 0.001
Asthma medication
None 324 (54) 65 (42) 119 (52) 140 (65) < 0.001
Bronchodilators 87 (15) 36 (23) 32 (14) 19 (9)
Inhaled corticosteroids 162 (27) 52 (34) 61 (27) 49 (23)
Oral corticosteroids 24 (4) 2 (1) 15 (7) 7 (3)
Smoking history
Non-smokers 334 (54) 147 (92) 70 (30) 117 (52) < 0.001
Ex-smokers 135 (22) 5 (3) 71 (31) 59 (26)
Smokers 146 (24) 8 (5) 91 (39) 47 (21)
Oral tobacco use 84 (14) 24 (15) 41 (18) 19 (9) < 0.05
Emergency visits ever
None 358 (59) 82 (52) 134 (58) 142 (64) 0.16
‡1 emergency department visit 128 (21) 36 (23) 53 (23) 39 (17)
‡hospitalization 125 (20) 40 (25) 43 (19) 42 (19)
Sick-leave during last 12 months
None 526 (85) 118 (74) 197 (85) 211 (95) < 0.001
1–8 days 37 (6) 20 (13) 16 (7) 1 (0)
8–30 days 44 (7) 20 (13) 16 (7) 8 (4)
30–90 days 5 (1) 1 (1) 3 (1) 1 (0)
>90 days 4 (1) 1 (1) 1 (0) 2 (1)
Living in an apartment 190 (33) 31 (21) 74 (32) 85 (43) < 0.001
Living in a city 371 (64) 102 (69) 152 (67) 117 (57) < 0.05
Health-related quality of life in asthmatics 61No signiﬁcant interaction was found between
age and symptom severity (P = 0.89). Neither age
nor gender seemed to modify the effect of hyper-
responsiveness to irritants on quality of life
(P = 0.82 and 0.88, respectively).
Discussion
In this cross-sectional study of determinants of quality
of life in people with clinically veriﬁed asthma, the
results show that female sex, smoking habits, higher
airway responsiveness to irritants, respiratory symp-
tom severity, positive skin prick test, and absenteeism
from work/school were signiﬁcantly associated with
health-related quality of life.
To our knowledge this is the ﬁrst study of deter-
minants of quality of life in asthmatics using the
Gothenburg Quality of Life instrument. One ﬁnding
of this study is that women with asthma report poorer
HRQL than men. Several other studies have also
found that women with asthma experience greater
impairment of the health-related quality of life
(5,6,16) despite the fact that women had, on average,
a higher lung function than men. The explanation
could be that women have a poorer overall health
compared to men, additional co-morbidities contrib-
uting to the HRQL impact, or that women have a
more severe asthma disease in terms of subjective
disease parameters. Asthma in women has been
hypothesized to be related to natural changes in
sex-steroid hormone levels during a woman’s life,
which might be an explanation. In particular,
women’s airways are the subject of cyclical variations
of sex hormones that occur in relation to circadian
rhythms, menstrual cycles, hormonal contraceptive
use, pregnancy, and menopause (17).
It has been suggested that women are more emo-
tionally distressed by the sheer presence of asthma
symptoms, while men do not react until their symp-
toms become severe and long-standing (16). Osborne
and co-workers also reported that women had more
symptoms and poorer HRQL than men. They sug-
gested that the differences could be related to the
response to the disease rather than real differences in
the disease between men and women. In a recent
review on sex differences in asthma it was also noted
that women with asthma report a greater number of
unscheduled physician visits, more frequent use of
oral corticosteroids, and a greater use of short-
acting beta-agonists for rescues than men. Under-
standing gender differences in response to chronic
disease such as asthma is important in tailoring man-
agement plans to each individual patient (18). Phy-
sicians should think about that men may have poor
pulmonary function levels, despite the fact that they
may not be bothered by their disease, while women’s
complaints concerning their asthma should be taken
seriously (19).
Current and former smokers reported lower health-
related quality of life in the present study. A previous
study shows that asthmatics who were current smo-
kers had lower lung function and more co-morbidity,
wheezing, and hyper-responsiveness than non-
smoking asthmatics (6). Cigarette smoking appears
to be associated with more asthma symptoms in
adults. Smoking is also a life-style factor, and efforts
to assist people with asthma who smoke to change this
behaviour may help to improve their quality of life (3).
Our results are in line with a study showing that
smokers have a greater risk for severe asthma than
non-smokers (20).
In the present study, respiratory symptom severity
was also found to be a determinant of low HRQL, but
a higher number of symptoms also seems to have a
worse impact on mental well-being in women than in
men. This is in accordance with other studies showing
that low HRQL was primarily related to asthma
symptoms (6) and with another study showing that
there was a relationship between respiratory symp-
toms and anxiety as well as depression (21). In con-
trast, asthma was not found to be related to anxiety
and depression in a population study (22).
The youngest age group had positive allergy tests
and higher airway responsiveness to irritants signiﬁ-
cantly more often than the two older age groups.
The social well-being in the youngest age group
Table I. (Continued).
All (n = 616) 16 y (n = 160) 30–39 y (n = 233) 60–69 y (n = 223) P value
Health-related quality of life
Symptom score 3.7 ± 1.3 4.0 ± 1.1 3.8 ± 1.4 3.7 ± 1.3 0.12
Social well-being 5.4 ± 0.9 5.4 ± 0.9 5.3 ± 0.9 5.5 ± 1.0 < 0.05
Physical well-being 4.2 ± 0.8 4.4 ± 0.8 4.3 ± 0.8 4.1 ± 0.8 < 0.001
Mental well-being 5.1 ± 1.0 5.2 ± 1.0 5.1 ± 1.1 5.1 ± 1.0 0.57
aPollen, pets, mites, and mould.














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Health-related quality of life in asthmatics 63was signiﬁcantly lower than in the two older age
groups, but the physical well-being was signiﬁcantly
higher. In contrast, another study found that the
physical well-being was lower in the younger age
group (16). Allergic rhinitis remains a signiﬁcant
health problem because of the high burden of symp-
toms and its impact on general well-being and HRQL
(23). A possible explanation for the low social well-
being in the youngest age group can be that adoles-
cents and younger children are in a developmental
stage of their life and are therefore struggling with
several issues that can be difﬁcult to handle due to
changes in the pattern of the disease and also the
demands of everyday life (24).
The oldest age group had signiﬁcantly more
symptoms, lower lung function, and used more
asthma medication. They had a signiﬁcantly poorer
physical well-being score than the two younger age
groups. Ford and co-workers demonstrated clearly
that asthma signiﬁcantly affected HRQL among the
elderly (3). Furthermore, Larsson and co-workers
reported that older women with asthma reported
the worst HRQL impairments (16). In general, stud-
ies have found that quality of life in asthma is worse
among older patients than among younger patients
(25). Among the elderly, co-morbidities probably
account for some of the associations with poor or
fair health. However, in this study diseases other than
asthma were excluded in the analysis.
Absenteeism from work and school was associated
with lower quality of life. Ford and co-workers found















Figure 2. Distribution of the Gothenburg Quality of Life instrument subscales by sex. Solid dots indicate mean values, and solid line
segments inside the boxes indicate the 25th, 50th, and 75th percentiles, respectively. Small ticks indicate observations outside the 5th and
95th percentiles. The x-axis represents the score on the seven-step Likert scale ranging from 1 = ‘very bad’,t o7= ‘excellent/could not be
better’.
64 M. Leander et al.impaired HRQL (3). A plausible explanation for this
association is that subjects are unable to work or go to
school because of their asthma and this contributed to
lower HRQL. There can also be life-style and socio-
economic factors that add to the complexities of this
issue. Unfortunately this study did not include such
variables.
The strength of this study is the clinically veriﬁed
asthma diagnosis and the validated quality of life
instrument, but the results are also subject to
some limitations. As this was a cross-sectional study,
the cause and effect of these associations cannot
be determined. Another limitation is the lack of
socio-economic classiﬁcation, but type of dwelling
(apartment or house) as well as living in the city or
country-side were used together as a surrogate marker.
Unfortunately, weight was not registered. Despite this,
we believe that our results contribute to the knowledge
of quality of life in asthma.
In conclusion, this study identiﬁed factors associ-
ated with poor HRQL in people with clinically ver-
iﬁed asthma. The results suggest that a number of
factors such as sex, smoking habits, airway respon-
siveness to irritants, respiratory symptom severity,
allergy, and absenteeism from school and work
are associated with HRQL in asthmatics. Women
with asthma report lower HRQL than men. A better
understanding of the factors associated with HRQL
in asthma is important in order to improve asthma
management.
Acknowledgements
This study was supported ﬁnancially by the Swedish
Heart and Lung Foundation, the Gävleborg County
Council Research Fund, the Swedish Association
against Asthma and Allergy, Uppsala County Asso-
ciation for Heart and Lung Disease, and Bror Hjerp-
steds Stiftelse.
Declaration of interest: The authors report no
conﬂicts of interest. The authors alone are responsible
for the content and writing of the paper.
References
1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of
asthma: executive summaryof the GINADissemination Com-
mittee report. Allergy. 2004;59:469–78.
2. Lotvall J, Ekerljung L, Ronmark EP, Wennergren G,
Linden A, Ronmark E, et al. West Sweden Asthma Study:
prevalence trends over the last 18 years argues no recent
increase in asthma. Respir Res. 2009;10:94.
3. Ford E, Mannino D, Redd S, Moriarty D, Mokdad A. Deter-
minants of quality of life among people with asthma: ﬁndings
from the Behavioral Risk Factor Surveillance System.
J Asthma. 2004;41:327–36.
4. Leander M, Cronqvist A, Janson C, Uddenfeldt M, Rask-
Andersen A. Non-respiratory symptoms and well-being in asth-
matics from a general population sample. J Asthma. 2009;46:
552–9.
5. Sundberg R, Palmqvist M, Tunsäter A, Toren K. Health-
related quality of life in youngadults with asthma. Respir Med.
2009;103:1580–5.
6. Hanneke A, Wijnhoven H, Didi M, Kriegsman W, Arlette E.
Hesselink, et al. Determinants of different dimensions of
disease severity in asthma and COPD. Chest. 2001;119:
1034–42.
7. Leander M, Cronqvist A, Janson C, Uddenfeldt M, Rask-
Andersson A. Health-related quality of life predicts onset of
asthma in a longitudinal population study. Resp Med. 2009;
103:194–200.
8. Larsson L, Boethius G, Uddenfeldt M. Differences in utilisa-
tion of asthma drugs between two neighbouring Swedish
provinces: relation to prevalence of obstructive airway disease.
Thorax. 1994;49:41–9.
9. Lundbäck B, Nyström L, Rosenhall L, Stjernberg N. Obstruc-
tive lung disease in northern Sweden. Respiratory symptoms
assessed in a postal survey. Eur Resp J.. 1991;4:257–66.
10. Medical Research Council’s Committee on the Aetiology of
Chronic Bronchitis: Standardised questionnaires on respira-
tory symptoms. Br Med J. 1960;2:1665.
11. Tibblin G, Tibblin B, Peciva S, Kullman S, Svärdsudd K.
“The Göteborg Quality of Life Instrument”—an assessment
of well-being and symptoms among men born 1913 and 1923.
Scand J Prim Health Care Suppl. 1990;1:33–8.
12. Standards for the diagnosis and care of patients with chronic
obstructive pulmonary disease (COPD) and asthma. This
ofﬁcial statement of the American Thoracic Society was
adopted by the ATS Board of Directors, November 1986.
Am Rev Respir Dis.. 1987;136:225–44.
13. Bousquet PJ, Chinn S, Janson C, Kogevinas M, Burney P,
Jarvis D. Allergy. Geographical variation in the prevalence of
positive skin tests to environmental aeroallergens in the
European Community Respiratory Health Survey I. 2007;6:
301–9.
14. Schafer JL, Graham JW. Missing data: our view of the state of
the art. Psychol Methods. 2002;7:147–77.
15. Royston P. Multiple imputation of missing values. The Stata
Journal. 2004;4:227–41.
16. Larsson U, Taft C, Karlsson J, Sullivan M. Gender and age
differences in the relative burden of rhinitis and asthma on
health-related quality of life—A Swedish population study.
Respir Med. 2007;101:1291–8.
17. Murphy VE, Gibson PG. Premenstrual asthma: prevalence,
cycle-to-cycle variability and relationship to oral cont-
raceptive use and menstrual symptoms. J Asthma. 2008;45:
696–704.
18. Kynyk JA, Mastronarde JG, McCallister JW. Asthma, the sex
difference. Curr Opin Pulm Med. 2011;17:6–11.
19. Wijnhoven HA, Kriegsman DM, Snoek FJ, Hesselink AE,
de Haan M. Gender differences in health-related quality of
life among asthma patients. J Asthma. 2003;40:189–99.
20. Stallberg B, Lisspers K, Hasselgren M, Johansson G,
Svardsudd K. Factors related to the level of severity of asthma
in primary care. Respir Med. 2007;101:2076–83.
21. Neuman Å, Gunnbjörnsdottir M, Tunsäter A, Nyström L,
Franklin K, Norrman E, et al. Dyspnea in relation to symp-
toms of anxiety and depression: a prospective population
study. Respir Med. 2006;100:1843–949.
Health-related quality of life in asthmatics 6522. Janson C, Bjornsson E, Hetta J, Boman G. Anxiety and
depression in relation to respiratory symptoms and asthma.
Am J Respir Crit Care Med. 1994;149:930–4.
23. Canonica GW, Bousquet J, Mullol J, Scadding GK,
Virchow JC. A survey of the burden of allergic rhinitis in
Europe. Allergy. 2007;62(Suppl 85):17–25.
24. de Benedictis D, Bush A. The challenge of asthma in ado-
lescence. Pediatr Pulmonol. 2007;42:683–92.
25. Osborne ML, Vollmer WM, Linton KL, Buist AS. Charac-
teristics of patients with asthma within a large HMO:
a comparison by age and gender. Am J Respir Crit Care
Med. 1998;157:123–8.
66 M. Leander et al.